Previous Article | Next Article ![]()
Journal of Virology, March 1999, p. 1756-1766, Vol. 73, No. 3
Department of Immunology, The Scripps
Research Institute, La Jolla, California 92037
Received 19 October 1998/Accepted 12 November 1998
Coxsackievirus infection causes severe pancreatitis and myocarditis
in humans, often leading to death in young or immunocompromised individuals. In susceptible strains of mice, coxsackievirus strain CB4
causes lethal hypoglycemia. To investigate the potential of gamma
interferon (IFN-
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Protection from Lethal Coxsackievirus-Induced
Pancreatitis by Expression of Gamma Interferon
) in protection and clearance of the viral infection, IFN-
knockout mice and transgenic (Tg) mice specifically expressing IFN-
in their pancreatic
cells were infected with CB4. Lack of IFN-
in mice normally resistant to CB4-mediated disease
resulted in hypoglycemia and rapid death. However, expression of
IFN-
in the
cells of Tg mice otherwise susceptible to lethal infection allowed for survival and protected them from developing the
accompanying hypoglycemia. While all the mice had high levels of viral
replication in their pancreata and comparable tissue pathology
following viral infection, the Tg mice had significantly lower levels
of virus at the peak of infection, significantly higher numbers of
activated macrophages before and after infection, and less damage to
their acinar tissue. Additionally, despite having increased levels of
inducible nitric oxide synthetase (iNOS) expression, treatment of Tg
mice with the iNOS inhibitor aminoguanidine did not alter the level of
protection afforded by IFN-
expression. In conclusion, IFN-
protects from lethal coxsackievirus infection by activating macrophages
in an iNOS-independent manner.
*
Corresponding author. Mailing address: Department of
Immunology (IMM-23), The Scripps Research Institute, 10550 N. Torrey Pines Rd., La Jolla, CA 92037. Phone: (619) 784-9066. Fax: (619) 784-9083. E-mail: noras{at}scripps.edu.
This is manuscript number 11674-IMM from The Scripps Research Institute.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|